Feb 01, 2019 - GlaxoSmithKline (GSK) closed at $39.20 in the latest trading session, marking no change from the prior day.
Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Feb 14, 2019 - Top Ranked Income Stocks to Buy for February 14th
Feb 14, 2019 - AstraZeneca (AZN) beats earnings and sales estimates in the fourth quarter and provides encouraging outlook for 2019. Shares up.
Feb 14, 2019 - Johnson & Johnson (JNJ) entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies focused on lung cancer, for approximately $3.4 billion in cash.
Feb 19, 2019 - Bayer (BAYRY) obtains full exclusive licensing rights for the global development and commercialization of Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195) from Loxo.
Feb 21, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda monotherapy for the third-line treatment of small cell lung cancer, a difficult-to-treat cancer, gets FDA's priority review.
Feb 22, 2019 - Top Ranked Income Stocks to Buy for February 22nd
Feb 26, 2019 - The Zacks Analyst Blog Highlights: Boeing, GlaxoSmithKline and Rio Tinto
Feb 27, 2019 - Top Ranked Income Stocks to Buy for February 27th